KZA — Kazia Therapeutics Share News
0.000.00%
Last trade - 00:00HealthcareSpeculativeMicro Cap
- AU$18.24m
- AU$14.80m
- AU$0.02m
Australia Stock Exchange release from KAZIA THERAPEUTI : PRE_NR Ends: 12:19:18
Australia Stock Exchange release from KAZIA THERAPEUTI : Notification regarding unquoted securities - KZA
Australia Stock Exchange release from KAZIA THERAPEUTI : PRE_NR Ends: 10:37:31
Australia Stock Exchange release from KAZIA THERAPEUTI : Quarterly Activities/Appendix 4C Cash Flow Report
Australia Stock Exchange release from KAZIA THERAPEUTI : Kazia Corporate Deck
Australia Stock Exchange release from KAZIA THERAPEUTI : Change of Director's Interest Notice
Australia Stock Exchange release from KAZIA THERAPEUTI : Change of Director's Interest Notice * 3
Australia Stock Exchange release from KAZIA THERAPEUTI : Change in substantial holding
Australia Stock Exchange release from KAZIA THERAPEUTI : Issue of shares
Brief: Kazia Therapeutics Appoints Karen Krumeich As Chief Financial Officer
Brief: Kazia Therapeutics Kazia Appoints Karen Krumeich As CFO
Australia Stock Exchange release from KAZIA THERAPEUTI : Kazia appoints Karen Krumeich as CFO
H.C. Wainwright sees 'catalyst-rich' 2022 for Australia's Kazia Therapeutics
Australia's Kazia Therapeutics jumps on positive study for brain tumour drug
Australia Stock Exchange release from KAZIA THERAPEUTI : PRE_NR Ends: 09:35:11
Australia Stock Exchange release from KAZIA THERAPEUTI : Kazia releases final data from P2 paxalisib trial
Australia Stock Exchange release from KAZIA THERAPEUTI : GBM Agile opens to paxalisib in Canada
Australia Stock Exchange release from KAZIA THERAPEUTI : Notification of cessation of securities - KZA
Australia Stock Exchange release from KAZIA THERAPEUTI : Notification regarding unquoted securities - KZA